Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Decline in prenatal buprenorphine/naloxone fills during the COVID-19 pandemic in the United States

View ORCID ProfileAshley L. O’Donoghue, Alyse Reichheld, Timothy S. Anderson, Chloe A. Zera, Tenzin Dechen, Jennifer P. Stevens
doi: https://doi.org/10.1101/2021.10.08.21264760
Ashley L. O’Donoghue
1Center for Healthcare Delivery Science, Beth Israel Deaconess Medical Center, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ashley L. O’Donoghue
  • For correspondence: aodonogh@bidmc.harvard.edu
Alyse Reichheld
1Center for Healthcare Delivery Science, Beth Israel Deaconess Medical Center, Boston, MA
2Tufts University School of Medicine, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy S. Anderson
1Center for Healthcare Delivery Science, Beth Israel Deaconess Medical Center, Boston, MA
3Division of General Medicine, Beth Israel Deaconess Medical Center, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chloe A. Zera
4Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tenzin Dechen
1Center for Healthcare Delivery Science, Beth Israel Deaconess Medical Center, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer P. Stevens
1Center for Healthcare Delivery Science, Beth Israel Deaconess Medical Center, Boston, MA
5Division for Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Data Availability

The data, technology, and services used in the generation of these research findings are restricted access and were generously supplied pro bono by the COVID-19 Research Database partners. Applications for access can be found at the following URL: https://covid19researchdatabase.org/.

https://covid19researchdatabase.org/

Back to top
PreviousNext
Posted October 11, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Decline in prenatal buprenorphine/naloxone fills during the COVID-19 pandemic in the United States
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Decline in prenatal buprenorphine/naloxone fills during the COVID-19 pandemic in the United States
Ashley L. O’Donoghue, Alyse Reichheld, Timothy S. Anderson, Chloe A. Zera, Tenzin Dechen, Jennifer P. Stevens
medRxiv 2021.10.08.21264760; doi: https://doi.org/10.1101/2021.10.08.21264760
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Decline in prenatal buprenorphine/naloxone fills during the COVID-19 pandemic in the United States
Ashley L. O’Donoghue, Alyse Reichheld, Timothy S. Anderson, Chloe A. Zera, Tenzin Dechen, Jennifer P. Stevens
medRxiv 2021.10.08.21264760; doi: https://doi.org/10.1101/2021.10.08.21264760

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Addiction Medicine
Subject Areas
All Articles
  • Addiction Medicine (227)
  • Allergy and Immunology (504)
  • Anesthesia (110)
  • Cardiovascular Medicine (1238)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (531)
  • Epidemiology (10020)
  • Forensic Medicine (5)
  • Gastroenterology (499)
  • Genetic and Genomic Medicine (2452)
  • Geriatric Medicine (236)
  • Health Economics (479)
  • Health Informatics (1642)
  • Health Policy (752)
  • Health Systems and Quality Improvement (636)
  • Hematology (248)
  • HIV/AIDS (533)
  • Infectious Diseases (except HIV/AIDS) (11864)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (252)
  • Medical Ethics (74)
  • Nephrology (268)
  • Neurology (2280)
  • Nursing (139)
  • Nutrition (352)
  • Obstetrics and Gynecology (454)
  • Occupational and Environmental Health (536)
  • Oncology (1245)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (157)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (730)
  • Pharmacology and Therapeutics (312)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2280)
  • Public and Global Health (4832)
  • Radiology and Imaging (837)
  • Rehabilitation Medicine and Physical Therapy (491)
  • Respiratory Medicine (651)
  • Rheumatology (285)
  • Sexual and Reproductive Health (238)
  • Sports Medicine (227)
  • Surgery (267)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)